Mutation Status of <i>RAS, TP53</i> , and <i>SMAD4</i> is Superior to Mutation Status of <i>RAS</i> Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases

Abstract

<i>RAS</i> mutation status alone is not sufficient for precisely predicting prognosis after CLM resection.